Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-01-04Clinical Trial Update: Seroquel on Glucose Metabolism [Phase 4]
Phase 4 trial update on quetiapine (Seroquel) and its effects on glucose metabolism in schizophrenia; completed study.
-
CLINICAL_TRIALS trial_result · 2013-01-04Clinical Trial Update: CAFE Comparison of Atypicals in First Episode of Psychosis [Phase 3]
Phase 3 trial comparing atypical antipsychotics in first-episode psychosis has completed.
-
CLINICAL_TRIALS trial_result · 2013-01-04Clinical Trial Update: A Comparison of Seroquel vs. Risperidone in Schizophrenia [Phase 4]
A Phase 4 trial comparing quetiapine (Seroquel) to risperidone for schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2013-01-04Clinical Trial Update: Seroquel Switching Study: Feasibility of Switching Any Antipsychotic Treatment to Seroquel in Patients With Schizophrenia [Phase 3]
This Phase 3 trial evaluated the feasibility of switching patients with schizophrenia from any antipsychotic to Seroquel (quetiapine); the s…
-
CLINICAL_TRIALS trial_result · 2013-01-04Clinical Trial Update: Immediate Release (IR) to Sustained Release (SR) Switching Study: Study of Switching From IR Seroquel to SR Seroquel in Outpatients With Schizophrenia [Phase 3]
A Phase 3 clinical trial update indicates the completion of a study evaluating switching outpatients with schizophrenia from immediate-relea…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-01-03Clinical Trial Update: Metabolic Signatures and Biomarkers in Schizophrenia [Phase 1]
A Phase 1 study from Duke University evaluating metabolic signatures and biomarkers in schizophrenia has completed and posted results.
-
FDA approval · 2012-12-31FDA Approved: RISPERIDONE — Supplemental Application (Ajanta Pharma USA Inc.)
FDA approved a supplemental application for risperidone from Ajanta Pharma USA Inc., enabling a new generic risperidone product.
-
CLINICAL_TRIALS trial_result · 2012-12-27Clinical Trial Update: The Evaluation of Therapeutic Efficacy on the Integrated Group Psychotherapy for Patients With Schizophrenia [NA]
A completed clinical trial evaluating the efficacy of integrated group psychotherapy for patients with schizophrenia.
-
CLINICAL_TRIALS trial_result · 2012-12-24Clinical Trial Update: A Drug Interaction Study of Valproic Acid and Single-dose Paliperidone Extended-Release (ER) in Healthy Men [Phase 1]
Phase 1 study assessing the drug interaction between valproic acid and a single dose of paliperidone extended-release in healthy men; the st…
-
CLINICAL_TRIALS trial_result · 2012-12-21Clinical Trial Update: A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Sublingual Asenapine in a Pediatric Population With Schizophrenia or Bipolar I Disorder (P06522 AM1) [Phase 1]
Phase 1 study evaluating pharmacokinetics, safety and tolerability of sublingual asenapine in pediatric patients with schizophrenia or Bipol…
-
FDA approval · 2012-12-20FDA Approved: RISPERIDONE — Supplemental Application (Amici Pharma, Inc.)
FDA approves a supplemental application for risperidone from Amici Pharma, Inc.
-
CLINICAL_TRIALS trial_result · 2012-12-20Clinical Trial Update: Atypical Antipsychotics in the Treatment of Affective Symptoms of Schizophrenia in Hungary
AstraZeneca-sponsored trial in Hungary evaluating atypical antipsychotics for affective symptoms in schizophrenia has completed.
-
FDA approval · 2012-12-19FDA Approved: RISPERIDONE — Supplemental Application (Amneal Pharmaceuticals LLC)
The FDA approved a supplemental application from Amneal Pharmaceuticals LLC for risperidone (generic), marking an update to its approval und…
-
CLINICAL_TRIALS trial_result · 2012-12-19Clinical Trial Update: Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder [Phase 4]
NIMH-sponsored Phase 4 clinical trial comparing antipsychotics for metabolic problems in schizophrenia and schizoaffective disorder with res…
-
CLINICAL_TRIALS trial_result · 2012-12-17Clinical Trial Update: Contingent Incentives Plus Bupropion for Smoking in People With Schizophrenia [Phase 2]
Phase 2 trial evaluating whether contingent incentives plus bupropion improves smoking cessation in people with schizophrenia; results have …
-
CLINICAL_TRIALS trial_result · 2012-12-17Clinical Trial Update: A Study of Subjects Switched to Lurasidone for the Treatment of Schizophrenia or Schizoaffective Disorder [Phase 3]
Phase 3 study evaluating switching to lurasidone for schizophrenia or schizoaffective disorder; results were posted after completion in 2012…
-
CLINICAL_TRIALS trial_result · 2012-12-17Clinical Trial Update: Intranasal Insulin Treatment in Patients With Schizophrenia [Phase 4]
Phase 4 trial updates on intranasal insulin in patients with schizophrenia; results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-12-13Clinical Trial Update: Recovery From Psychosis in Schizophrenia - The Impact of Cognitive-Behavioral Therapy [NA]
This entry reports the completion of a clinical trial evaluating the impact of cognitive-behavioral therapy on recovery from psychosis in in…
-
FDA approval · 2012-12-12FDA Approved: RISPERIDONE — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for risperidone submitted by Zydus Lifesciences Limited.
-
CLINICAL_TRIALS trial_result · 2012-12-12Clinical Trial Update: Efficacy Study of Panax Ginseng to Boost Antipsychotics Effects in Schizophrenia [Phase 1, Phase 2]
A completed Phase 1/Phase 2 study assessed whether Panax ginseng can enhance the efficacy of antipsychotics in schizophrenia and schizoaffec…
-
CLINICAL_TRIALS trial_result · 2012-12-07Clinical Trial Update: A Study of Treatment Success in Changing From Olanzapine to Long-acting Injectable Risperidone (RISPERDAL® CONSTA™) [Phase 4]
Phase 4 study evaluating treatment success when switching patients with schizophrenia or psychotic disorders from oral olanzapine to the lon…
-
CLINICAL_TRIALS trial_result · 2012-12-05Clinical Trial Update: rTMS Effects on Smoking Cessation and Cognition in Schizophrenia [NA]
A completed clinical trial evaluated repetitive transcranial magnetic stimulation (rTMS) for smoking cessation and cognitive outcomes in ind…
-
CLINICAL_TRIALS research · 2012-11-30Clinical Trial Update: Non-interventional Study: Real-life Use of Atypical Antipsychotics in Acute Inpatient Management of Schizophrenia
AstraZeneca-sponsored non-interventional study evaluating real-life use of atypical antipsychotics in the acute inpatient management of schi…
-
CLINICAL_TRIALS trial_result · 2012-11-29Clinical Trial Update: Olanzapine Given in Combination With Zonisamide SR to Prevent Weight Gain in Schizophrenic Subjects [Phase 2]
Phase 2 clinical trial evaluating olanzapine in combination with zonisamide sustained-release to prevent weight gain in patients with schizo…
-
CLINICAL_TRIALS trial_result · 2012-11-27Clinical Trial Update: A Study to Evaluate the Safety and the Effects of Risperidone Compared With Other Atypical Antipsychotic Drugs on the Growth and Sexual Maturation in Children [Phase 4]
Phase 4 study comparing risperidone with other atypical antipsychotics in children to assess safety and impact on growth and sexual maturati…